Design, synthesis, in vitro and in silico anticancer activity evaluation of novel thiosemicarbazide/butanoic acid hybrids
3e was found to have selective cytotoxic activity against cancer cells, which didn’t cause significant damage to non-cancerous cells, and may be effective on cancer patients without showing any side effects.